Why it ranks
How the rank works- went through YCProgram · this site+4
- team of 2Team size · YC's directory+2.5
A sum of public facts, not a judgement and not investment advice.
Also from F26
All of F26About BioDelivera
BioDelivera has developed proprietary GCV™, a drug delivery platform designed to travel through the body and selectively target diseased cells while sparing healthy ones. GCVs can carry genetic medicines, DNA, RNA, small molecules, or combinations of these at the same time. BioDelivera has demonstrated efficacy in tumors, muscle, and brain and is expanding to additional tissues. The company’s mission is to enable cures for every patient, across every disease.
- YC batch
- F26 · Fall 2026
- Status, per YC
- Active
- Category
- Other
- Team size
- 2
- Location
- San Francisco, CA, USA
- Checked
- 6h ago
YC tags: Gene Therapy, Cell Therapy, Drug Delivery
Changes seen
Joined Y Combinator's Fall 2026 batch (F26).
BioDelivera: questions
Which YC batch was BioDelivera in?
BioDelivera was in Y Combinator's Fall 2026 batch (F26).
Is BioDelivera still active?
Y Combinator lists BioDelivera as active.
Where is BioDelivera based?
BioDelivera lists San Francisco, CA, USA as its location on YC's directory.